President William Ruto has announced that Kenya will introduce injectable HIV treatment starting in 2026, marking a major step toward the country’s ambition of ending AIDS as a public health threat by 2030. The president said the move is part of an aggressive national strategy to modernize HIV care and improve long-term treatment outcomes.
Unlike daily oral tablets that many patients struggle to take consistently, the new injectable treatment will be administered once every two months, offering a more convenient and discreet option. According to Ruto, the innovation is expected to boost adherence, reduce stigma, and enhance the quality of life for thousands of Kenyans living with HIV.
Health experts have long argued that simplifying treatment is key to slowing new infections and supporting those already diagnosed. The president noted that Kenya is positioning itself at the forefront of adopting advanced medical technologies across Africa.
The announcement has been widely welcomed by healthcare workers, HIV advocates, and researchers, who say the 2026 rollout could transform community health programs. Many view it as a strong signal of Kenya’s seriousness in meeting the global target of ending AIDS by 2030.
As preparations begin, the Ministry of Health is expected to work with international partners, research institutions, and pharmaceutical manufacturers to ensure affordability, accessibility, and adequate training for health personnel.
If successful, the new treatment model could become one of the most significant breakthroughs in Kenya’s fight against HIV in decades.
